Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
NCT ID: NCT05672498
Last Updated: 2023-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2023-01-05
2023-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In recent years, the project applicant has been conducting research on the anti infection and anti inflammation treatment of traditional Chinese medicine, and has carried out a lot of clinical practice exploration in non-specific inflammation.
The purpose of this research is to study the therapeutic effect of a traditional Chinese medicine prescription on COVID-19 infection.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
NCT04251871
Traditional Chinese Medicine for Severe COVID-19
NCT04323332
Effect of Traditional Chinese Medicine of Severe COVID-19
NCT06714032
The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue
NCT05684952
TCM Differentiation and Treatment Protocol of COVID-19
NCT04306497
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TCM treatment
The patients are treated with traditional Chinese medicine. They take 150ml of liquid medicine every morning and evening for 7 days.
Traditional Chinese Medicine Formulation
The TCM Treatment Group：The patient are given a traditional Chinese medicine formulation, taking 150 ml of liquid medicine every morning and evening for 7 days.
placebo treatment
The patients are treated with placebo. They take 150ml of liquid placebo every morning and evening for 7 days .
Placebo Treatment
Placebo Treatment Group:The patient are given placebo, taking 150 ml of liquid placebo every morning and evening for 7 days. All medications and placebo are packed identically in packing bags with the same labeling form.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Traditional Chinese Medicine Formulation
The TCM Treatment Group：The patient are given a traditional Chinese medicine formulation, taking 150 ml of liquid medicine every morning and evening for 7 days.
Placebo Treatment
Placebo Treatment Group:The patient are given placebo, taking 150 ml of liquid placebo every morning and evening for 7 days. All medications and placebo are packed identically in packing bags with the same labeling form.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 ≤ age ≤ 65, regardless of gender;
* Patients have good follow-up compliance.
Exclusion Criteria
* Any drug that may interfere with the evaluation (for example, other herbal products such as Lianhua Qingwen, immunosuppressants, anticoagulants), or a history of allergy or other adverse reactions to traditional Chinese medicine products.
* Pregnant or lactating women.
* Allergic constitution and allergy to multiple drugs.
* According to the judgment of the investigator, the subject suffers from any disease that may endanger his safety or affect his compliance with the protocol, or other conditions that are not suitable for the study.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bingyin Shi
Role: STUDY_CHAIR
First Affilicated Hospital of Xian Jiaotong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affilicated Hospital of Xian Jiaotong University
Xi’an, Shanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XJTU1AF2022LSK-436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.